Credits: Canva
For over 15 years, Dr Anthony Shum, a pulmonologist at the University of California, San Francisco has been studying a rare genetic disorder called the COPA Syndrome. It stands for coatomer subunit alpha and is a rare, inherited disorder that affects the lungs, joint, and kidney. The National Organization for Rare Disorder also notes that it is a genetic autoimmune disorder that is caused by mutations in the COPA gene. This disease affects families unpredictably—some individuals with the mutation develop severe lung damage early in life, while others remain completely healthy. Now, Shum’s team has discovered a protective genetic variant that may offer new hope for treatment.
Researchers found that some relatives of COPA Syndrome patients stayed healthy despite carrying the same COPA gene mutation that causes the disease. The key difference? These unaffected individuals had a protective version of another gene called HAQ-STING.
When scientists introduced HAQ-STING into diseased lung cells from COPA patients, the cells returned to a balanced state, suggesting that this gene could be used as a therapy.
“We really think HAQ-STING could be a gene therapy tool and a step toward a cure,” said Shum, whose findings were published in the Journal of Experimental Medicine.
Shum’s journey into COPA Syndrome research began in 2011 when he treated a young woman, Letasha, who had severe lung bleeding. Her mother, Betty Towe, mentioned that Letasha’s sister, Kristina, had suffered from similar symptoms. Over the years, Betty had taken both daughters on a four-hour trip to UCSF for treatment. After tracing their family history, Shum discovered that their distant relatives in Texas and Oakland also had lung problems and arthritis. In 2015, Shum, along with scientists from Baylor College of Medicine and Texas Children’s Hospital identified the COPA gene mutation. They realized that it was the common factor behind the illness. However, only some of the 30 individuals with the mutation actually developed symptoms, leaving a major question unanswered.
It was established that it occurs when a mutated COPA gene causes another gene STING to go overdrive. The STING that helps fight infections in COPA patients, remain permanently active, which leads to chronic inflammation that damages the lungs, kidneys, and joints. In 2020, while studying STING’s role in the disease, researchers discovered a key variation: HAQ-STING. This version of STING, present in about one-third of the population, appeared to neutralize the harmful effects of the COPA mutation.
To confirm their theory, the scientists needed both affected and unaffected family members to participate in the testing. Letasha, Kristina and Betty immediately volunteered. The researchers then analyzed DNA samples from 26 COPA patients and their healthy relatives. They also conducted CT scans and blood tests to ensure that unaffected members did not have any hidden symptoms. When the findings were all clear, it was revealed that all the healthy individuals had HAQ-STING, while none of the COPA patients did. This was the first known case of a common gene variant completely protecting against a severe genetic disease.
Encouraged by this discovery, researchers tested HAQ-STING’s effects in a lab setting. They introduced it into diseased lung cells from COPA patients, and the cells returned to normal function.
Shum believes HAQ-STING could lead to game-changing treatments, including:
Before publishing their findings, Shum called Betty with the news—her own HAQ-STING gene had protected her from the disease. He also informed Letasha and Kristina, who were overwhelmed with relief and joy.
“We always believed Dr. Shum would get to the bottom of it,” said Letasha. “This discovery is going to change lives.”
Credit: AI
Doctors have reached a major milestone in minimally invasive lung care. They have removed a suspected endobronchial carcinoid tumor from a patient's airway without needing to perform open chest surgery. The procedure combined four advanced bronchoscopic techniques to successfully remove the tumour while saving the patient’s lung tissue.
A 40 year old male patient from Gurugram came in with breathlessness. Additional examinations revealed partially obstructing the airway and interfering with the patient’s normal breathing. Because of where the tumour was and what it looked like, doctors decided to do the advanced bronchoscopic procedure rather than a more invasive surgery.
Also read: Is It Just A Persistent Cough Or Is Your Body Telling You Something Else?
Endobronchial carcinoid tumours are slow growing but highly vascular and can bleed profusely when excised. Precise instrumentation, careful planning and efficient control of bleeding are required to treat them within the narrow air passage. To overcome these challenges the team employed a multimodality approach that included flexible fibreoptic bronchoscopy to access and visualise the tumour, electrocautery to cut and debulk the growth, Argon Plasma Coagulation (APC) to seal blood vessels and control bleeding and cryotherapy to freeze and extract tumour tissue and treat the residual base.
The combined approach allowed the team to completely remove the tumour and restore airway patency with no need for an external incision. The patient [recovered well and was discharged within X days/is recovering well], while the excised tissue has been sent for histopathological examination to confirm the diagnosis.
Endobronchial tumours such as carcinoids can bleed heavily, so every step has to be planned in advance. By combining electrocautery, argon plasma coagulation and cryotherapy through a flexible bronchoscope, we were able to remove the tumour completely while keeping bleeding under control. For carefully selected patients, this approach can avoid open surgery and the loss of healthy lung tissue.
Traditionally, some endobronchial tumours have required surgical removal of the affected portion of the lung. Advances in interventional pulmonology are expanding treatment possibilities, allowing appropriately selected patients to undergo tumour removal through the natural airway. This approach can help avoid external incisions as well as reduce post procedure pain, shorten hospital stays and support faster recovery.
This achievement shows just how important advanced therapeutic bronchoscopy has become for treating complex airway conditions.
Credit: AI
Lung cancer is usually linked to smoking yet there is more to the tale behind who gets the disease in India. More men suffer from lung cancer than women. This does not happen by coincidence because of the differences in the number of smokers.
According to the Global Cancer Observatory (GLOBOCAN 2022), lung cancer is one of the most common cancers among Indian males. There is a substantial difference in the prevalence rate of cancer between men and women, and the former group bears a higher burden of the disease. One needs to go deeper into the problem to find an explanation.
Tobacco consumption is one of the most important factors influencing the likelihood of suffering from cancer. Traditionally, smoking was a practice more common among men in India. According to the results of the Global Adult Tobacco Survey (GATS-2, 2016-17), about 24 per cent of Indian men had ever consumed tobacco, compared to just 14 per cent of women.
Cigarette smoke and bidis contain harmful chemicals that cause gradual damage to the tissues lining the airways. Such repeated exposure makes changes in genes more probable, which ultimately results in the occurrence of cancer. Moreover, the risk becomes higher depending on the length and severity of smoking.
Gender differences in the workforce in India may contribute to additional exposure to cancer-causing substances as well. Male employees in such occupations as construction, mining, manufacturing, transportation and some industries may be exposed to asbestos, silica dust, diesel engine exhausts and other hazardous agents. As a result, they become at greater risk of developing lung cancer due to long-term exposure.
Air pollution may contribute to an increase in the risk of lung cancer as well. Inhalation of fine particulates, especially PM2.5, is able to penetrate deeply into the lungs and cause cancer. According to IARC, outdoor air pollution and particulate matter are carcinogenic to humans.
Nevertheless, women may suffer from environmental risk factors too. Inhalation of smoke caused by solid fuel combustion in kitchens with poor ventilation and passive exposure to cigarette smoke pose additional risks for female patients.
Also read: Lung Cancer Survival Improves By 71% In US: But 1 In 5 Patients Still Gets No Treatment
One common myth is that lung cancer only affects smokers. Some women develop lung cancer without any history of smoking. Some lung cancers, especially some kinds of adenocarcinomas, occur in people with no past of smoking. These cancers could have unique features and genetic mutations that could assist in identifying targeted therapy for this condition.
This is why an individual assessment of each case of lung cancer is necessary rather than jumping to conclusions about what caused the cancer based on whether one smokes or not.
While men might disregard cough, shortness of breath, or chest pains as being results of smoking, pollution, or age, women might struggle with the same problem due to the fact that they do not smoke.
A persistent cough for weeks, bloody sputum, unintentional weight loss, constant chest pain, or an increasing level of breathlessness is never to be dismissed. Symptoms like these do not always mean cancer, yet they need a proper medical evaluation.
Gender differences in the incidence of lung cancer depend on behavioral, environmental, occupational, and biological factors. It is essential to stop smoking, create safe workplaces, reduce pollution of the air, and have an early diagnosis for both men and women.
Lung cancer cannot be viewed as a man's disease or the outcome of smoking. The chances might differ, but it needs to be universally recognized and treated.
Credit: iStock
Even if diabetes is kept under control kidney function can still get worse over time. Good control of blood sugar cuts the risk of kidney disease a lot but it does not remove the risk entirely.
The risk depends on things, such as how long one has had diabetes years of poor blood sugar control, high blood pressure being overweight genes and heart disease. Sometimes kidney damage that started when blood sugar was high before can keep showing up after blood sugar improves later.
One key point is that HbA1c by itself does not show kidney health. A person may have a HbA1c of 6.5 percent yet still have early kidney damage with no signs. That is why regular kidney screening is vital.
I recommend two tests for every person with diabetes: urine albumin-to-creatinine ratio, called UACR and estimated glomerular filtration rate, called eGFR. These tests reveal kidney damage early before any symptoms. People with type 2 diabetes should have these tests at once a year.
In addition to blood sugar control keeping blood pressure low staying at a healthy weight exercising often avoiding needless painkillers and quitting smoking are key ways to protect kidneys. New medicines, SGLT2 inhibitors and for some people, finerenone have shown strong kidney protection
Controlling blood sugar matters. Protecting kidneys needs more than just diabetes control. Regular screening and early treatment can greatly lower the chance of kidney disease and the need, for dialysis.
By Dr. Ronak Bhalodia, Dr NB Nephrology, MD Medicine, Sterling Hospital, Rajkot
© $2026 Times Horizon Private Limited